Document is current
Any future updates will be listed below
-
Authors
Lazreg, Sihem https://orcid.org/0000-0002-6310-9615
Assaf, Ahmed Hassan https://orcid.org/0000-0001-7663-5043
Abdelrahman, Ahmed M. https://orcid.org/0000-0003-3459-2924
Hosny, Mohamed https://orcid.org/0000-0002-7243-0224
Shaheen, Mohamed Shafik
Shawky, Medhat Mohamed
El-Raggal, Tamer Mohamed https://orcid.org/0000-0002-0084-9683
Abou Samra, Waleed Ali Moustafa https://orcid.org/0000-0001-7730-6049
Mostafa, Yehia Salah Eldin https://orcid.org/0000-0001-6482-1543
-
Funding
Funding for this research was provided by:
Orchidia Pharmaceutical Industry
- License Information
-
More Information
Article History
Received: 22 July 2024
Accepted: 6 January 2025
First Online: 20 January 2025
Declarations
:
: This study and its investigators were fully sponsored and funded by Orchidia Pharmaceutical Industry.
: The protocol and its amendments were submitted to independent ethics committees (IECs) of "Genuine Research Center (GRC)" under study code "GRC/ORCDT/EG/37/CT", protocol code number "ORC-001" for review and written approval. It complied with recommendations of the 18th World Health Congress (Helsinki, 1964), laws and regulations, and any applicable guidelines.
: All patients signed written informed consent.
